JPH067114A - Production of aqueous of nucleic acid - Google Patents
Production of aqueous of nucleic acidInfo
- Publication number
- JPH067114A JPH067114A JP4191661A JP19166192A JPH067114A JP H067114 A JPH067114 A JP H067114A JP 4191661 A JP4191661 A JP 4191661A JP 19166192 A JP19166192 A JP 19166192A JP H067114 A JPH067114 A JP H067114A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- aqueous solution
- temperature
- powder
- absorption efficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【０００１】[0001]
【産業上の利用分野】本発明は、所定効能を有し核酸を
含有する命の源（商標）粉末を、安定的な水溶液と成し
て吸収効率を上昇させると共に、種々な使用方法を可能
とする様にした核酸水の製造方法に関するものである。INDUSTRIAL APPLICABILITY The present invention forms a stable aqueous solution of Life Source (trademark) powder having a predetermined effect and containing a nucleic acid to increase absorption efficiency and enables various uses. The present invention relates to a method for producing nucleic acid water.
【０００２】[0002]
【従来の技術】従来、命の源粉末はそのまま或いは水、
コーヒー、紅茶、牛乳、日本酒、ウィスキー、ワイン等
の多種多様な飲み物に混入して服用し、人体組織の活性
化等を行う効能を有しているが、命の源は経時変化を防
止するために粉末状態であるので、粉末のまま服用した
時には人体の体液、主に胃液（胃酸）で水溶するが、完
全な水溶液に同化、或いは水溶液と体液が共鳴しないと
共に体液と比較して大幅に濃度が上昇し、胃腸等におけ
る吸収効率が悪い欠点を有していた。2. Description of the Related Art Conventionally, the source powder of life is as it is or with water,
It has the effect of activating human body tissues by mixing it with a wide variety of drinks such as coffee, tea, milk, sake, whiskey, and wine, but the source of life is to prevent changes over time. Since it is in powder form, when taken as a powder, it is soluble in human body fluids, mainly gastric fluid (gastric acid), but is assimilated into a complete aqueous solution, or the aqueous solution and body fluid do not resonate and the concentration is significantly higher than body fluid. And the absorption efficiency in the gastrointestinal tract was poor.
【０００３】又、人体への吸収効率を上昇させるため
に、単純に水溶液と成した場合には次の理由による経時
変化により使用不可能な水溶液となり、例えば空気感染
等により水溶液中に雑菌、有害菌が混入した時には、か
かる雑菌等が増殖したり、或いは核酸が水溶液中の栄養
素等と結合して自然醗酵状態となって二次物質が増殖し
たり核酸が変質したりする欠点を有し、これらの増殖、
変質等により核酸含有水溶液が混濁したり、沈澱する欠
点を有していた。Further, in order to increase the absorption efficiency into the human body, when it is simply made into an aqueous solution, it becomes an unusable aqueous solution due to the change over time due to the following reasons. When mixed with bacteria, such miscellaneous bacteria grow, or have the drawback that nucleic acids bind to nutrients in an aqueous solution and become a natural fermentation state, and secondary substances grow or nucleic acids deteriorate, These proliferation,
It has a drawback that the nucleic acid-containing aqueous solution becomes cloudy or precipitates due to alteration or the like.
【０００４】[0004]
【発明が解決しようとする課題】本発明は、吸収効率を
上昇させるために核酸含有水溶液と成すと共に、増殖、
変質等の経時変化を防止する様にした核酸水の製造方法
を提供せんとするものである。DISCLOSURE OF THE INVENTION The present invention comprises a nucleic acid-containing aqueous solution for increasing absorption efficiency, growth,
An object of the present invention is to provide a method for producing nucleic acid water which prevents deterioration over time.
【０００５】[0005]
【課題を解決するための手段】本発明は、上記従来技術
に基づく、核酸含有の命の源粉末は吸収効率が悪い課
題、及び水溶液は経時変化が発生する課題に鑑み、１０
０℃以上で加熱することによって、雑菌等の滅菌を行う
と共に核酸を仮死状態とする様にし、又体内温度近傍で
所定時間放置することによって、核酸が体内吸収された
時に核酸が活性化、活動再開する様にして、上記課題を
解決せんとしたものである。SUMMARY OF THE INVENTION The present invention is based on the above-mentioned prior art, and in view of the problem that the nucleic acid-containing powder of life source has a poor absorption efficiency and the aqueous solution causes a change with time.
By heating at 0 ° C or higher to sterilize various bacteria and to put the nucleic acid into an asphyxia state, and leaving it at a temperature near the body temperature for a predetermined time, the nucleic acid is activated and activated when absorbed into the body. The above problem was solved by restarting.
【０００６】[0006]
【作用】本発明にあっては、所定効能を有する命の源粉
末を体内吸収効率が良好な水溶液と成し、又雑菌等を加
熱により死滅させ、核酸には体内温度の近似温度を記憶
させた後に仮死状態と成し、体内吸収時に活動再開させ
る。In the present invention, the source powder of life having a predetermined effect is formed into an aqueous solution having a good absorption efficiency in the body, and various bacteria are killed by heating, and the nucleic acid is made to store the approximate temperature of the body temperature. After that, it becomes asphyxia and resumes activity when absorbed into the body.
【０００７】[0007]
【実施例】以下本発明の一実施例を説明すると、核酸
（ＤＮＡ、ＲＮＡ）を含有する命の源（商標）粉末は下
記の様な核酸成分、栄養成分、アミノ酸成分等を含有
し、これらの成分、特に核酸成分が体内吸収された時に
健康増進作用、自然治癒力の促進作用、老化防止作用等
を有するものである。EXAMPLES An example of the present invention will be described below. A source of life (trademark) powder containing nucleic acids (DNA, RNA) contains the following nucleic acid components, nutritional components, amino acid components, etc. When it is absorbed in the body, the component, especially the nucleic acid component, has an effect of promoting health, an action of promoting natural healing power, an action of preventing aging and the like.
【０００８】[0008]
【表１】 [Table 1]
【０００９】[0009]
【表２】 [Table 2]
【００１０】[0010]
【表３】 [Table 3]
【００１１】[0011]
【表４】 [Table 4]
【００１２】[0012]
【表５】 [Table 5]
【００１３】次に本発明に係る核酸水の製造方法につい
て説明すると、上記の核酸含有粉末の水溶液は下記の３
工程で製造され、先ず第１工程としては、精製水１００
〜１５０ｃｃに対して２〜４ｇの核酸粉末を混入し、こ
の粉末含有精製水を室温で２０〜３０時間、ゆすりビン
による振動作用で充分に混合させて、精製水に対して粉
末を充分に、完全に溶解、同化させる。Next, the method for producing nucleic acid water according to the present invention will be described.
The first step is the purified water 100
˜150 cc of nucleic acid powder is mixed with 2 to 4 g, and the powder-containing purified water is sufficiently mixed at room temperature for 20 to 30 hours by vibrating action of a shaking bottle to sufficiently mix the powder with purified water. Completely dissolve and assimilate.
【００１４】第２工程としては、上記の核酸含有水溶液
を密閉し、３５〜４５℃の温度で２０〜３０時間放置
し、核酸にかかる温度を記憶、覚え込ませるのであり、
該温度は体内（内臓）温度３８℃以上に符号、関連し、
記憶作用は細胞、その分子、核酸等の本来持っている作
用に関係し、又３５℃以下では核酸の活動が低下し、４
５℃超過では核酸が分解する傾向を有している。In the second step, the nucleic acid-containing aqueous solution is hermetically sealed and left at a temperature of 35 to 45 ° C. for 20 to 30 hours to store and remember the temperature of the nucleic acid.
The temperature is associated with a body (visceral) temperature of 38 ° C or higher,
The memory effect is related to the original function of cells, their molecules, nucleic acids, etc., and the activity of nucleic acids decreases below 35 ° C,
Nucleic acids tend to decompose at temperatures above 5 ° C.
【００１５】第３工程としては、第２工程を終了した水
溶液を密閉容器に入れ、１００〜１５０℃で２〜５分程
度加熱処理して雑菌、有害菌を滅菌すると共に、核酸が
上記温度を記憶したまま仮死（一時休止）状態と成し、
上記３工程で源液としての核酸水を製造する。In the third step, the aqueous solution obtained after the second step is put in a closed container and heat-treated at 100 to 150 ° C. for about 2 to 5 minutes to sterilize various bacteria and harmful bacteria, and the nucleic acid is kept at the above temperature. I was in an asphyxia (temporary pause) state as I remembered,
Nucleic acid water as a source solution is produced in the above three steps.
【００１６】尚、上記３工程において、特に第１、２工
程はクリーンな環境下において行うことが望ましい。It is desirable that the above three steps, especially the first and second steps, be performed in a clean environment.
【００１７】次に第２、３工程において加熱等により濃
度上昇した上記水溶液を１００〜１０００倍程度に希釈
し、健康飲料水とする場合には１日の飲用回数に応じて
１０００倍程度に希釈して、体液に近似する濃度の水溶
液と成して体内吸収効率を上昇させ、又人体表面に塗布
使用する化粧水等の場合には吸収効率が向上する１００
倍程度に希釈し、表皮の活性化を行って染み、皺を薄く
し、又かかる核酸水は人体以外にも植物の活性化、発育
向上作用を有し、かかる涵養水としての用途においても
希釈する。Next, in the second and third steps, the aqueous solution whose concentration has been increased by heating or the like is diluted about 100 to 1000 times, and when it is used as healthy drinking water, it is diluted about 1000 times according to the number of times of drinking per day. Then, the absorption efficiency in the body is increased by forming an aqueous solution having a concentration similar to that of body fluid, and the absorption efficiency is improved in the case of toner such as a lotion applied on the surface of the human body.
Dilute about twice and activate the epidermis to stain and thin wrinkles.The nucleic acid water also has the effect of activating plants and improving growth in addition to the human body, and is diluted even in the use as such recharge water. To do.
【００１８】次に本発明の製造方法による核酸水の作用
について説明すると、上記の様な３工程及び希釈工程を
経て製造された核酸水は、体内吸収された時に、核酸は
体内温度に曝され、感化して第２工程の放置温度を記憶
しているために、仮死状態から脱して活動再開し、他方
第３工程による加熱処理を行っていることにより、雑菌
等は死滅すると共に核酸は一時休止状態のため、核酸水
は経時変化しない。Next, the action of the nucleic acid water according to the production method of the present invention will be explained. When the nucleic acid water produced through the above-mentioned three steps and the dilution step is absorbed in the body, the nucleic acid is exposed to the body temperature. However, since it sensitizes and memorizes the left-over temperature of the 2nd step, it resumes its activity after leaving the asphyxia state, while the heat treatment by the 3rd step kills bacteria and the nucleic acid Due to the dormant state, the nucleic acid water does not change over time.
【００１９】[0019]
【発明の効果】要するに本発明は、核酸を含有する粉末
を精製水に混入して水溶液と成したので、粉末状態より
も体内吸収効率を向上することが出来たり、化粧水、植
物の涵養水としても使用出来、又水溶液を３５〜４５℃
で所定時間放置したので、核酸はかかる温度を記憶し、
体内吸収された時に体内温度３８℃以上で活動再開する
ことが出来、又その後かかる水溶液を１００〜１５０℃
で所定時間加熱する様にしたので、雑菌等は死滅すると
共に核酸は仮死状態となり、核酸含有水溶液は要冷蔵を
不要として常温保管及び長期間の使用においても、品質
等が変化せず半永久的な使用が出来る等その実用的効果
甚だ大なるものである。INDUSTRIAL APPLICABILITY According to the present invention, since the powder containing a nucleic acid is mixed with purified water to form an aqueous solution, the absorption efficiency in the body can be improved more than in the powder state, and the lotion and the recharge water for plants can be improved. Can be used as a
Since it was left for a predetermined time, the nucleic acid remembers the temperature,
When it is absorbed by the body, it can resume its activity at a body temperature of 38 ° C or higher, and then the aqueous solution at 100 to 150 ° C.
Since it is heated for a predetermined time, bacteria and other bacteria are killed and the nucleic acid is in an asphyxia state, and the nucleic acid-containing aqueous solution is semi-permanent with no change in quality even at room temperature storage and long-term use without requiring refrigeration Its practical effect, such as its use, is enormous.
Claims (1)
水溶液と成し、該水溶液を３５〜４５℃で所定時間放置
し、その後かかる水溶液を１００〜１５０℃で所定時間
加熱する様にしたことを特徴とする核酸水の製造方法。1. A method in which a powder containing a nucleic acid is mixed with purified water to form an aqueous solution, the aqueous solution is allowed to stand at 35 to 45 ° C. for a predetermined time, and then the aqueous solution is heated at 100 to 150 ° C. for a predetermined time. A method for producing nucleic acid water, comprising:
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4191661A JPH067114A (en) | 1992-06-24 | 1992-06-24 | Production of aqueous of nucleic acid |
| KR1019930011443A KR940005660A (en) | 1992-06-24 | 1993-06-23 | Method of producing nucleic acid solution |
| FR9307690A FR2692897B3 (en) | 1992-06-24 | 1993-06-24 | Process for the preparation of an aqueous solution containing at least one nucleic acid. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4191661A JPH067114A (en) | 1992-06-24 | 1992-06-24 | Production of aqueous of nucleic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH067114A true JPH067114A (en) | 1994-01-18 |
Family
ID=16278360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4191661A Pending JPH067114A (en) | 1992-06-24 | 1992-06-24 | Production of aqueous of nucleic acid |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPH067114A (en) |
| KR (1) | KR940005660A (en) |
| FR (1) | FR2692897B3 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
-
1992
- 1992-06-24 JP JP4191661A patent/JPH067114A/en active Pending
-
1993
- 1993-06-23 KR KR1019930011443A patent/KR940005660A/en not_active Application Discontinuation
- 1993-06-24 FR FR9307690A patent/FR2692897B3/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2692897A1 (en) | 1993-12-31 |
| FR2692897B3 (en) | 1994-09-02 |
| KR940005660A (en) | 1994-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362637B (en) | Method for removing nitrite in edible bird's nest by using microbial viable bacteria suspension and/or crude enzyme liquid and application | |
| WO2006042222B1 (en) | Carbonated protein drink and method of making | |
| CN102260621A (en) | Production method of fermented lily wine | |
| CN105602793A (en) | Preparation method of osmanthus wine | |
| JP2004510402A (en) | Acidic solution of poorly soluble group IIA complex | |
| JPH0195730A (en) | Production of feed | |
| JP5348851B2 (en) | Method for producing basic cosmetic liquid phase component using microorganism | |
| JPH067114A (en) | Production of aqueous of nucleic acid | |
| RU2154945C1 (en) | Method of bread production | |
| Sabbatani et al. | The long and dramatic history of surgical infections | |
| JP2008099578A (en) | Zinc yeast and method for producing the same | |
| CN108902828A (en) | The method of more wheel salting zymolysis pickles | |
| US20180027842A1 (en) | Process for the treatment of white liquid egg | |
| JP3569693B2 (en) | Aloe vera fermented extract beverage and method for producing the same | |
| JPS63209539A (en) | Preparation of 'takuan' | |
| KR101740147B1 (en) | Method of reducing biogenic amines | |
| CN105754835B (en) | A kind of production method of honey raisin tree fruit vinegar | |
| KR100203175B1 (en) | Presevation and preparation of fermented alcoholic beverage | |
| Sedgwick | The origin, scope and significance of bacteriology | |
| CN109619502A (en) | A kind of microbial fermentation pickled vegetable making technique | |
| JPS61247366A (en) | Sterilization of non-heated food | |
| JP2015054192A (en) | Production method of cold water of scallop liquid | |
| US1564385A (en) | Concentrated enzymic substance and method of preparing same | |
| JP2004267121A (en) | Method for producing herbed amazake | |
| JPS6014996A (en) | Treatment of waste water produced in food manufacture and the like |